Medical device acquirers spent something in the neighborhood of $1.5 billion over the past few months on transcatheter mitral valve replacement acquisitions to treat just 80 patients, half of whom are now dead, Boston Scientific (NYSE:BSX) chief medical officer Dr. Keith Dawkins said today. “There’s been, really [since] a few months ago, $1.5 billion, roughly, spent […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Update: PE shop Aurora Capital buys Cardiac Science
Update: Added legal information on the bankruptcy sale Private equity firm Aurora Capital Group said today it acquired the assets of Cardiac Science in a court-approved sale. The buy was approved by U.S. Bankruptcy Judge Robert Martin, and included a $65 million credit bid and an agreement from Aurora to take on other liabilities including real […]
St. Jude Medical rejiggers sales reporting
St. Jude Medical (NYSE:STJ) said today that it plans to rejigger the way it reports its sales to better reflect its focus in managing the business, beginning this year. Little Canada, Minn.-based St. Jude, which saw its share price slide today after missing forecasts for its 4th-quarter sales, said it’s focus is shifting to 5 key key areas: Heart failure; atrial […]
J&J joins Edwards in $28m Series B for arterial shunt dev V-Wave
Johnson & Johnson (NYSE:JNJ) joined previous investor Edwards Lifesciences (NYSE:EW) in a $28 million Series B round to support heart failure treating interarterial shunt maker V-Wave, according to a press release posted yesterday. Other groups joining the round included newly-invested TriVentures, Pura Vida Investments and BioStar Ventures, with returning investors Pontifax and the BRM group. “With the […]
Neovasc wins FDA nod to expand Tiara TMVR trial
Neovasc (NSDQ:NVCN) said today that it won approval from the FDA to expand a clinical trial of its Tiara transcatheter mitral valve implant to include a larger valve size. Vancouver-based Neovasc said the federal safety watchdog approved the use of the 40mm Tiara device in its 30-patient Tiara-I early feasibility study, which was already approved […]
FDA approves LivaNova’s Perceval heart valve
The FDA approved the Perceval sutureless replacement heart valve made by LivaNova (NSDQ:LIVN) (the company formed by the union of Sorin and Cyberonics), the company said today. London-based LivaNova said it plans to begin commercial distribution of the Perceval valve, which is designed to replace the heart’s aortic valve using a self-anchoring frame. “We are excited to […]
Pi-Cardia pulls in $10m for Leaflex aortic valve catheter
Stealthy Pi-Cardia said today that it raised $10 million from a consortium that includes a mystery strategic investor for its Leaflex treatment for aortic stenosis. Rehovot, Israel-based Pi-Cardia’s Leaflex is a catheter-based procedure designed to use mechanical energy to crack the calcification on aortic valve leaflets to return them to normal function. The company said […]
BiO2 Medical drums up $9m Series D for Angel catheter
BiO2 Medical said yesterday that it raised a $9 million Series D round for its Angel catheter, after concluding its pivotal clinical trial a year ahead of schedule. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San […]
Endotronix pulls in $3.5m for wireless heart monitor
Endotronix raised $3 million and is looking to bring in another $540,000 in a new round of debt financing, according to an SEC filing posted last week. Woodridge, Ill.-based Endotronix develops wireless cardiac monitors, including a ‘tiny pressure sensor’ designed to be implanted in a patient’s pulmonary artery during a catheterization procedure, to wirelessly return PA […]
HeartWare shareholder threatens proxy fight over Valtech merger
HeartWare International (NSDQ:HTWR) may face a proxy battle from a shareholder over its proposed acquisition of Israeli replacement heart valve maker Valtech Cardio, according to an SEC filing posted yesterday. The company said it received a notice from shareholding firm Engaged Capital nominating 3 board members and opposing its proposed acquisition of Valtech. “While we […]
Study: U.S. patients subject to higher radiation during MPI heart test
Americans undergoing myocardial perfusion imaging to diagnose coronary artery disease, a leading killer in the U.S., are receiving higher levels of radiation than their peers around the world, according to a new study. The study was published in JAMA Internal Medicine this month. The MPI test, performed on millions of U.S. patients every year, is […]